XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statement of cash flows, indirect method (Statement) - BRL (R$)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from (used in) operating activities      
Net income (loss) for the period R$ (7,044,706,000) R$ 14,106,381,000 R$ 23,394,887,000
Adjustments to reconcile profit (loss)      
Depreciation, depletion and amortization 8,874,931,000 6,999,839,000 7,206,125,000
Depreciation, right-of-use assets 349,064,000 321,271,000 231,966,000
Interest expense on lease liabilities 451,148,000 441,596,000 433,613,000
Result from sale and disposal of property, plant and equipment, intangible and biological assets, net 163,033,000 331,285,000 509,000
Income (expense) from associates and joint ventures 13,845,000 19,379,000 (284,368,000)
Exchange rate and monetary variations, net 15,884,993,000 (3,087,727,000) (3,294,593,000)
Interest expenses on financing, loans and debentures 5,413,707,000 4,797,094,000 4,007,737,000
Adjustments for finance costs (959,968,000) (1,160,364,000) (359,407,000)
Accrual of interest on marketable securities (1,254,424,000) (1,352,522,000) (707,211,000)
Amortization of transaction costs, premium and discounts 80,099,000 67,353,000 69,881,000
Derivative financial instruments, net 9,112,683,000 (5,526,714,000) (6,761,567,000)
Result on fair value adjustment of biological assets (1,431,530,000) (1,989,831,000) (1,199,759,000)
Deferred income tax and social contribution (7,431,946,000) 3,495,443,000 4,749,798,000
Interest on actuarial liabilities and cost of current service 75,850,000 69,231,000 59,258,000
Provision for judicial liabilities, net 138,318,000 139,934,000 88,198,000
Provision (reversal) for doubtful accounts, net 2,585,000 35,202,000 1,652,000
Provision (reversal) for inventory losses, net 77,353,000 31,419,000 56,060,000
Provision (reversal) for loss of ICMS credits, net 130,727,000 348,628,000 58,003,000
Other 69,535,000 66,938,000 4,118,000
Trade accounts receivable (808,785,000) 2,155,448,000 (3,267,356,000)
Inventories (863,648,000) (48,673,000) (967,995,000)
Recoverable taxes (95,411,000) (666,681,000) (381,408,000)
Other assets 6,185,000 328,800,000 (95,382,000)
Trade accounts payable 2,164,832,000 463,003,000 1,533,118,000
Taxes payable 296,169,000 329,556,000 422,591,000
Payroll and charges 364,817,000 73,096,000 83,742,000
Other liabilities (27,706,000) (277,538,000) (9,007,000)
Cash generated from operations 23,751,750,000 20,510,846,000 25,061,889,000
Payment of interest on financing, loans and debentures (5,241,389,000) (4,728,998,000) (4,019,072,000)
Capitalized loan costs paid 959,968,000 1,160,364,000 359,407,000
Interest received on marketable securities 1,500,437,000 681,268,000 544,849,000
Payment of income taxes (366,339,000) (308,002,000) (306,453,000)
Cash provided by operating activities 20,604,427,000 17,315,478,000 21,640,620,000
Additions to property, plant and equipment (9,190,589,000) (11,674,183,000) (9,791,238,000)
Additions to intangible (162,042,000) (104,931,000) (90,499,000)
Purchase of biological assets (7,180,450,000) (5,777,952,000) (4,957,380,000)
Proceeds from sales of property, plant and equipment and biological assets 167,983,000 183,576,000 251,183,000
Capital increase in affiliates (41,281,000) (48,462,000) (67,020,000)
Marketable securities, net 205,954,000 (5,296,370,000) 67,426,000
Advances for acquisition of wood from operations with development and partnerships (294,952,000) (690,908,000) (355,362,000)
Dividends received 44,789,000 6,604,000
Asset acquisition (Notes 1.2.6 and 1.2.7) (2,595,974,000) (1,615,140,000) (2,090,062,000)
Acquisition of subsidiaries (1,060,718,000)
Increase (decrease) through acquisition of other investments 1,440,503,000
Net cash from acquisition of subsidiaries (note 1.2.6) 19,113,000 5,002,000 10,590,000
Cash used in investing activities (20,512,741,000) (26,035,297,000) (17,015,758,000)
Proceeds from loans, financing and debentures 15,692,905,000 10,944,794,000 1,335,715,000
Proceeds from derivative transactions (550,581,000) 3,559,286,000 282,225,000
Payment of loans, financing and debentures (9,410,807,000) (4,296,447,000) (2,517,934,000)
Payment of leases (1,325,398,000) (1,218,399,000) (1,044,119,000)
Payment of interest on own capital and dividends (1,624,653,000) (192,532,000) (4,150,782,000)
Liabilities for assets acquisitions and subsidiaries (58,467,000) (116,924,000) (107,888,000)
Shares repurchased (2,806,764,000) (880,914,000) (1,904,424,000)
Cash provided (used) by financing activities (83,765,000) 7,798,864,000 (8,107,207,000)
EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS 665,026,000 (239,125,000) (602,480,000)
Increase (Decrease) in cash and cash equivalents, net 672,947,000 (1,160,080,000) (4,084,825,000)
At the beginning of the year 8,345,871,000 9,505,951,000 13,590,776,000
At the end of the year 9,018,818,000 8,345,871,000 9,505,951,000
Adjustments for Sublease of Ships R$ (11,314,000)